Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa

Journal of Clinical Microbiology

Volumn 50, Issue 2, 2012, Pages 525-527

  Brink, Adrian J ^a   Coetzee, Jennifer ^b   Clay, Cornelis G ^b   Sithol, Sindi ^c   Richards, Guy A ^d   Poirel, Laurent ^e   Nordmann, Patrice ^e  

^a MILPARK HOSPITAL   (South Africa)

^b National Referral Laboratory   (South Africa)

^c Ampath Trust   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; C REACTIVE PROTEIN; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DORIPENEM; ERTAPENEM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; METALLO BETA LACTAMASE; METRONIDAZOLE; NEW DELHI METALLO BETA LACTAMASE 1; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; AGED; ANKLE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL GENE; BLOOD CULTURE; CASE REPORT; CENTRAL VENOUS CATHETER; CHRONIC KIDNEY FAILURE; CLOSTRIDIUM DIFFICILE INFECTION; DELIRIUM; DETERIORATION; ENTEROBACTER CLOACAE; FEMALE; FEVER; HEMODIALYSIS; HIP FRACTURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPOTENSION; INFERIOR CAVA VEIN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LEUKOCYTOSIS; LOADING DRUG DOSE; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NEW DELHI METALLO BETA LACTAMASE 1 GENE; OPEN REDUCTION; OSTEOSYNTHESIS; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY ARREST; RESUSCITATION; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE DRUG DOSE; SOUTH AFRICA; SPUTUM ANALYSIS; THORAX DRAINAGE; TRACHEAL ASPIRATION PROCEDURE; URINALYSIS; URINE CULTURE; VENA CAVA FILTER; WOUND;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; SOUTH AFRICA;

ENTEROBACTER CLOACAE; KLEBSIELLA PNEUMONIAE;

EID: 84856162360     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05956-11     Document Type: Article

References (16)

1. Carmeli Y, et al. 2010. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin. Microbiol. Infect. 16:102-111.
2. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing. 21st informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Elliott E, et al. 2006. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase. Clin. Infect. Dis. 42:e95-e98.
4. European Committee on Antimicrobial Susceptibility Testing. 2009. Breakpoint tables for interpretation of MICs and zone diameters, version 1.0, December 2009. European Committee on Antimicrobial Susceptibility Testing, Basel, Switzerland.
5. Grundmann H, et al. 2010. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 15:1-13.
6. Hindiyeh M, et al. 2008. Rapid detection of blaKPC carbapenemase genes by real-time PCR. J. Clin. Micro. 46:2879-2883.
7. Hirsch EB, Tam VH. 2010. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J. Antimicrob. Chemother. 65:1119 -1125.
8. Kritsotakis EI, Tsioutis C, Roumbelaki M, Christidou A, Gikas A. 2011. Antibiotic use and the risk of carbapenem-resistant extended-spectrum- β-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J. Antimicrob. Chemother. 66:1383-1391.
9. Nordmann P, Cuzon G, Naas T. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9:228-236.
10. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798.
11. Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR. 2011. How to detect NDM-1 producers? J. Clin. Micro. 41:798-821.
12. Poirel L, Benouda A, Hays C, Nordmann P. 2011. Emergence of NDM-1-Producing Klebsiella pneumoniae in Morocco.J. Antimicrob. Chemother. 66:2781-2783.
13. Poirel L, Revathi G, Bernabeu S, Nordmann P. 2011. Detection of NDM-1-Producing Klebsiella pneumoniae in Kenya. Antimicrob. Agents Chemother. 55:934 -936.
14. Segal H, Elisha BG. 2006. Resistance to β-lactams, and reduced susceptibility to carbapenems, in clinical isolates of Klebsiella pneumoniae due to interplay between CTX-M 15 and altered outer membrane permeability. S. Afr. J. Epidemiol. Infect. 21:41-44.
15. Woodford N, et al. 2010. Comparison of BD Phoenix, Vitek 2, and Microscan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae. J. Clin. Micro. 48:2999-3002.
16. Zarfel G, et al. 2011. Emergence of New Delhi metallo-β-lactamase, Austria. Emerging Infect. Dis. 17:129-130.